Lucentis: Clinical Trials

2 trials of Lucentis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated. 2 Phase 2, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Terminated 2
Phase 32Terminated 2

Follow Lucentis: new trials by email Literature Review of Lucentis trials Research Report on Lucentis

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Assessment Of Age-related Macular Degeneration Patients After Early Diagnosis and Treatment With Ranibizumab
ranibizumab - Age-Related Macular Degeneration
Phase 2 / Phase 3TerminatedUniversity of California, San Diego202011-07-012019-08-28
Verteporfin Photodynamic Therapy Administered in Conjunction With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration (AMD)
Verteporfin Photodynamic Therapy, Ranibizumab, Placebo - Macular Degeneration, Choroidal Neovascularization
Phase 2 / Phase 3TerminatedNovartis2552007-05-012011-04-21

Conditions studied

Choroidal Neovascularization (2)  ·  Macular Degeneration (2)

Sponsors

Novartis (1)  ·  University of California, San Diego (1)

Countries

Austria (1)  ·  Belgium (1)  ·  Denmark (1)  ·  France (1)  ·  Germany (1)  ·  Hungary (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Poland (1)  ·  Spain (1)  ·  Switzerland (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Henry Ferreyra, MD (1)

Results publications

PMID 22424834, PMID 25079064